Clinical Trials · NCT06581120
GLP_1 RA Ultrasound Study
Enrolling By InvitationN/ATirzepatide (Investigational)Semaglutide (Investigational)Liraglutide (Investigational)Dulaglutide (Investigational)
- Phase
- N/A
- Recruitment status
- Enrolling By Invitation
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Enrollment
- 100
- Start date
- Jul 2024
- Locations
- 1 site, United States
- Primary endpoint
- Aspiration Risk determined by POGUS